SSI - 医索

找到约 173 条结果

Safety, tolerability and efficacy of 21Pb-DOTAMTATE asa targeted alpha therapy for subjects with unresectableor metastatic somatostatin receptor-expressinggastroenteropancreatic neuroendocrine

医客学院 - 会议报告集

Development and validation of Al-assisted transcriptomicsignatures to personalize adjuvant chemotherapy in patientswith resectable pancreatic ductal adenocarcinoma

医客学院 - 会议报告集

slides-Discussion_of_LBA1000.

医客学院 - 会议报告集

Abemaciclib plus fulvestrant vs fulvestrant alone for HR HER2-advanced breast cancer following progression onprior CDK46 inhibitor plus endocrine therapy Primaryoutcome of the Phase 3 postMONARCH

医客学院 - 会议报告集

Phase lalb trial of zongertinib (Bl 1810631),aHER2-specific tyrosine kinase inhibitor in patients withHER2 aberration-positive solid tumors updatedPhase la data from Beamion LUNG-1, includingprogression-

医客学院 - 会议报告集

Lorlatinib vs Crizotinib in Treatment-NaivePatients With Advanced ALK Non-SmallCell Lung Cancer 5-Year Progression-FreeSurvival and Safety From the CRoWN Study

医客学院 - 会议报告集

Classical and New Age Therapiesfor Colorectal Cancer

医客学院 - 会议报告集

Acquired gene alteration patterns and post-progressionsurvivalPARADIGM study analysis

医客学院 - 会议报告集

The 9th edition of TNM Classification for lung cancer

医客学院 - 会议报告集

posters-Expression_of_Nectin4_and_PDL1_in_bladder_cancer_w

医客学院 - 会议报告集

首页
上一页
1
2
3
4
5
...
17
18
下一页
尾页

今日实时热搜